A genetic variant associated with aggressive prostate cancer has been discovered by researchers at Wake Forest University Baptist Medical Center. Claiming their discovery as a “first,” the scientists say that one day genetic information may be used in combination with other factors to guide treatment decisions.
Men with low cholesterol face less risk of high-grade prostate cancer
Men with lower cholesterol are less likely than those with higher levels to develop high-grade prostate cancer — an aggressive form of the disease with a poorer prognosis, according to results of a Johns Hopkins collaborative study.
Why do some men with elevated prostate specific antigen (PSA) levels who are carefully monitored and undergo repeated negative biopsies still develop aggressive prostate cancer? Clinical researchers at Princess Margaret Hospital (PMH) in Toronto, Canada believe they can now answer that baffling question.